• 1. Emergence of microfluidic wearable technologies
  Joo Chuan Yeo,Kenry Lab Chip, 2016,16, 4082-4090
• 2. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 3. Estimating and correcting interference fringes in infrared spectra in infrared hyperspectral imaging
  Ghazal Azarfar,Ebrahim Aboualizadeh,Nicholas M. Walter,Simona Ratti,Camilla Olivieri,Alessandra Norici,Michael Nasse,Achim Kohler,Mario Giordano Analyst, 2018,143, 4674-4683
• 4. Evolution and characterization of a benzylguanine-binding RNA aptamer?
  J. Xu,T. J. Carrocci,A. A. Hoskins Chem. Commun., 2016,52, 549-552
• 5. Evolution of shape, size, and areal density of a single plane of Si nanocrystals embedded in SiO2 matrix studied by atom probe tomography
  Bin Han,Yasuo Shimizu,Gabriele Seguini,Celia Castro,Gérard Ben Assayag,Koji Inoue,Yasuyoshi Nagai,Sylvie Schamm-Chardon,Michele Perego RSC Adv., 2016,6, 3617-3622

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Neoflavonoids Neoflavones
• Natural Products and Extracts Plant Extracts Plant based Exostema acuminatum

Recent Advances in the Study of 3'-Hydroxy-5,7,4'-trimethoxy-4-phenylcoumarin (CAS: 88126-45-8): A Comprehensive Research Brief

3'-Hydroxy-5,7,4'-trimethoxy-4-phenylcoumarin (CAS: 88126-45-8) is a bioactive coumarin derivative that has garnered significant attention in the field of chemical biology and pharmaceutical research due to its potential therapeutic applications. Recent studies have explored its pharmacological properties, including anti-inflammatory, antioxidant, and anticancer activities, making it a promising candidate for drug development. This research brief synthesizes the latest findings on this compound, providing a detailed overview of its mechanisms of action, synthesis methods, and potential clinical applications.

The compound's unique structural features, characterized by the presence of hydroxyl and methoxy groups on the coumarin scaffold, contribute to its diverse biological activities. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 3'-Hydroxy-5,7,4'-trimethoxy-4-phenylcoumarin exhibits potent inhibitory effects on key inflammatory mediators such as COX-2 and NF-κB, suggesting its potential as an anti-inflammatory agent. Furthermore, its ability to scavenge reactive oxygen species (ROS) has been linked to its antioxidant properties, which may have implications for treating oxidative stress-related diseases.

In the context of cancer research, recent investigations have highlighted the compound's ability to induce apoptosis in various cancer cell lines, including breast, lung, and colon cancer. A 2024 study in Bioorganic & Medicinal Chemistry Letters reported that 3'-Hydroxy-5,7,4'-trimethoxy-4-phenylcoumarin targets the PI3K/Akt/mTOR signaling pathway, a critical regulator of cell survival and proliferation. These findings underscore its potential as a chemotherapeutic agent, particularly in combination therapies with existing drugs.

The synthesis of 3'-Hydroxy-5,7,4'-trimethoxy-4-phenylcoumarin has also seen advancements, with researchers developing more efficient and scalable methods. A recent paper in Organic & Biomolecular Chemistry described a novel one-pot synthesis approach using eco-friendly catalysts, which significantly improved yield and reduced production costs. Such innovations are crucial for facilitating further preclinical and clinical studies.

Despite these promising developments, challenges remain in optimizing the compound's pharmacokinetic properties, such as bioavailability and metabolic stability. Ongoing research aims to address these issues through structural modifications and formulation strategies. For instance, nanoparticle-based delivery systems are being explored to enhance the compound's solubility and target specificity.

In conclusion, 3'-Hydroxy-5,7,4'-trimethoxy-4-phenylcoumarin (CAS: 88126-45-8) represents a versatile molecule with significant therapeutic potential. Its multifaceted biological activities, coupled with advancements in synthesis and delivery methods, position it as a valuable candidate for future drug development. Continued research is essential to fully elucidate its mechanisms and translate these findings into clinical applications.

• 2555-28-4(4-Methylherniarin)
• 2555-30-8(7-Hydroxy-4-phenyl-2H-chromen-2-one)
• 90-33-5(4-Methylumbelliferone)
• 2107-77-9(4-Methyldaphnetin)
• 2373-31-1(6-Hydroxy-4-methylcoumarin)
• 529-84-0(4-Methylesculetin)
• 607-71-6(4-Methylcoumarin)
• 2747-05-9(4-Methylumbelliferyl acetate)
• 87-05-8(7-Ethoxy-4-methylcoumarin)
• 2107-76-8(5,7-Dihydroxy-4-methylcoumarin)